help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on July 19, 2007, doi:10.1165/rcmb.2007-0067OC

Am. J. Respir. Cell Mol. Biol., Volume 38, Number 1, January 2008, 38-46

A more recent version of this article appeared on January 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0067OCv1
38/1/38    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zindler, E.
Right arrow Articles by Sudowe, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zindler, E.
Right arrow Articles by Sudowe, S.

Submitted on March 1, 2007
Revised on July 19, 2007

Divergent Effects of Biolistic Gene Transfer in a Mouse Model of Allergic Airway Inflammation

Eva Zindler1, Nadine Gehrke1, Cornelia Luft1, Sebastian Reuter1, Christian Taube1, Susetta Finotto1, Angelika B Reske-Kunz1, and Stephan Sudowe1*

1 Department of Dermatology, University of Mainz, III. Medical Clinic, Clinical Research Unit Allergology I, Asthma Core Facility SFB 548,, Mainz, Germany

* To whom correspondence should be addressed. E-mail: sudowe{at}mail.uni-mainz.de.

Particle-mediated epidermal delivery (PMED) of allergen genes efficiently prevents systemic sensitization and suppresses specific IgE synthesis. We investigated in a mouse model of allergic airway disease the effect of PMED on the elicitation of local inflammatory reactions in the lung. BALB/c mice were biolistically transfected with plasmids encoding {beta}-galactosidase ({beta}Gal) as model allergen under control of the DC-targeting fascin promoter and the ubiquitously active CMV promoter, respectively. Mice were challenged intranasally with {beta}Gal-protein with or without intermediate sensitization with {beta}Gal adsorbed to aluminiumhydroxide. Subsequently local cytokine production and recruitment of IFN-{gamma} producing CD8+ effector T cells into the airways were determined, and inflammatory parameters such as cellular infiltration in the bronchoalveolar lavage and airway hyperresponsiveness (AHR) were measured. PMED of {beta}Gal-encoding plasmids prior to sensitization significantly reduced frequencies of eosinophils in the bronchoalveolar lavage and shifted the local Th cell response from a distinct Th2 response towards a Th1-biased response. However, AHR triggered by allergen challenge via the airways was not alleviated in vaccinated mice. Most important, we show that PMED using {beta}Gal-encoding DNA without subsequent sensitization recruited Tc1 cells into the lung and caused a Th1-prone local immune response following subsequent intranasal provocation, accompanied by neutrophilic infiltration into the airways and elicitation of AHR. We conclude that robust Th1/Tc1 immune responses, although highly effective in the counter-regulation of local Th2-mediated pathology, might as well trigger local inflammatory reactions in the lung and provoke the induction of AHR in the mouse model of allergic airway disease.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2007 American Thoracic Society.